Scott Henry
Stock Analyst at Alliance Global Partners
(1.61)
# 3,196
Out of 4,869 analysts
61
Total ratings
37.74%
Success rate
-5.3%
Average return
Main Sectors:
Stocks Rated by Scott Henry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNON Tenon Medical | Initiates: Buy | $3 | $0.90 | +232.04% | 1 | Apr 9, 2025 | |
| QSI Quantum-Si incorporated | Initiates: Buy | $3.75 | $1.73 | +116.76% | 1 | Feb 7, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $8.25 → $6 | $2.80 | +114.29% | 4 | Nov 19, 2024 | |
| LPCN Lipocine | Initiates: Buy | $10 | $3.30 | +203.03% | 1 | Sep 24, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $2.75 | $0.63 | +337.06% | 1 | May 28, 2024 | |
| DERM Journey Medical | Initiates: Buy | $8.5 | $6.54 | +29.97% | 2 | Feb 16, 2024 | |
| RNXT RenovoRx | Initiates: Buy | $4 | $1.38 | +189.86% | 3 | Feb 2, 2024 | |
| FBIO Fortress Biotech | Maintains: Buy | $30 → $15 | $1.78 | +742.70% | 2 | Nov 29, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $12 | $0.70 | +1,609.89% | 2 | Oct 30, 2023 | |
| CSBR Champions Oncology | Maintains: Buy | $9 → $7.5 | $8.20 | -8.54% | 2 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $13.85 | -6.14% | 4 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $24 | $26.01 | -7.73% | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $114.07 | -21.10% | 9 | Dec 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $16 | $22.48 | -31.05% | 2 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $58 | $81.78 | -29.08% | 6 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $58.29 | -38.24% | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $0.94 | +1,070.21% | 3 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $4.73 | +26.85% | 2 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $5,750 | $2.49 | +230,823.69% | 1 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.20 | - | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 | $2.42 | +189.26% | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $32.36 | - | 5 | Apr 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.57 | - | 2 | Mar 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.35 | - | 1 | Nov 10, 2017 |
Tenon Medical
Apr 9, 2025
Initiates: Buy
Price Target: $3
Current: $0.90
Upside: +232.04%
Quantum-Si incorporated
Feb 7, 2025
Initiates: Buy
Price Target: $3.75
Current: $1.73
Upside: +116.76%
Vivos Therapeutics
Nov 19, 2024
Maintains: Buy
Price Target: $8.25 → $6
Current: $2.80
Upside: +114.29%
Lipocine
Sep 24, 2024
Initiates: Buy
Price Target: $10
Current: $3.30
Upside: +203.03%
Assertio Holdings
May 28, 2024
Initiates: Buy
Price Target: $2.75
Current: $0.63
Upside: +337.06%
Journey Medical
Feb 16, 2024
Initiates: Buy
Price Target: $8.5
Current: $6.54
Upside: +29.97%
RenovoRx
Feb 2, 2024
Initiates: Buy
Price Target: $4
Current: $1.38
Upside: +189.86%
Fortress Biotech
Nov 29, 2023
Maintains: Buy
Price Target: $30 → $15
Current: $1.78
Upside: +742.70%
Reviva Pharmaceuticals Holdings
Oct 30, 2023
Reiterates: Buy
Price Target: $12
Current: $0.70
Upside: +1,609.89%
Champions Oncology
Sep 22, 2023
Maintains: Buy
Price Target: $9 → $7.5
Current: $8.20
Upside: -8.54%
Aug 16, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $13.85
Upside: -6.14%
May 3, 2023
Maintains: Buy
Price Target: $19 → $24
Current: $26.01
Upside: -7.73%
Dec 23, 2022
Maintains: Buy
Price Target: $85 → $90
Current: $114.07
Upside: -21.10%
Aug 24, 2022
Downgrades: Neutral
Price Target: $10 → $16
Current: $22.48
Upside: -31.05%
Aug 3, 2021
Maintains: Neutral
Price Target: $55 → $58
Current: $81.78
Upside: -29.08%
Aug 2, 2021
Maintains: Buy
Price Target: $32 → $36
Current: $58.29
Upside: -38.24%
May 12, 2021
Maintains: Buy
Price Target: $9 → $11
Current: $0.94
Upside: +1,070.21%
Feb 26, 2021
Maintains: Buy
Price Target: $4 → $6
Current: $4.73
Upside: +26.85%
Feb 16, 2021
Maintains: Buy
Price Target: $6,000 → $5,750
Current: $2.49
Upside: +230,823.69%
Dec 4, 2020
Downgrades: Neutral
Price Target: n/a
Current: $3.20
Upside: -
Nov 11, 2020
Upgrades: Buy
Price Target: $7
Current: $2.42
Upside: +189.26%
Apr 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $32.36
Upside: -
Mar 26, 2018
Downgrades: Neutral
Price Target: n/a
Current: $0.57
Upside: -
Nov 10, 2017
Downgrades: Neutral
Price Target: n/a
Current: $4.35
Upside: -